- Brand NameOLMEVASC
- Strength5+20 mg, 5+40 mg, 10+20 mg, 10+40 mg
- Dosage typeTablets
- therapeutic areaCardiovascular
INDICATION
For the management of patients with mild to severe hypertension, alone or with other antihypertensives.
Lowering blood pressure reduces the risk of fatal and non-fatal CV events, primarily stokes, coronary arteries disease & myocardial infarction.
Adjust dose after 2 to 4 weeks, as needed to a maximum of 10/25mg.